1. Home
  2. ENB vs SYK Comparison

ENB vs SYK Comparison

Compare ENB & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enbridge Inc

ENB

Enbridge Inc

HOLD

Current Price

$55.18

Market Cap

124.5B

Sector

Energy

ML Signal

HOLD

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$351.32

Market Cap

120.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENB
SYK
Founded
1949
1941
Country
Canada
United States
Employees
14800
N/A
Industry
Natural Gas Distribution
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.5B
120.7B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
ENB
SYK
Price
$55.18
$351.32
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$65.00
$415.57
AVG Volume (30 Days)
2.7M
2.0M
Earning Date
05-08-2026
04-30-2026
Dividend Yield
5.13%
1.12%
EPS Growth
N/A
8.25
EPS
N/A
1.93
Revenue
N/A
$25,116,000,000.00
Revenue This Year
N/A
$9.80
Revenue Next Year
$3.22
$8.44
P/E Ratio
$21.67
$178.77
Revenue Growth
N/A
11.16
52 Week Low
$44.80
$281.00
52 Week High
$58.45
$401.99

Technical Indicators

Market Signals
Indicator
ENB
SYK
Relative Strength Index (RSI) 49.61 64.60
Support Level $54.82 $348.46
Resistance Level $56.84 $352.80
Average True Range (ATR) 0.75 8.72
MACD -0.02 2.58
Stochastic Oscillator 43.56 95.00

Price Performance

Historical Comparison
ENB
SYK

About ENB Enbridge Inc

Enbridge owns extensive midstream assets that transport hydrocarbons across the US and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also operates regulated natural gas utilities in the US and Canada, including Canada's largest natural gas distribution company. The firm has a small renewable energy portfolio primarily focused on onshore and offshore wind projects.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: